Kromek Group awarded contract extension by DARPA

Kromek Group PLC (LON:KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, has today announced that it has been awarded an extension to its contract by the Defense Advanced Research Projects Agency, an agency of the US Department of Defense, to detect and identify pathogens in an urban environment. This follows successful completion of the base period of the contract which was awarded by DARPA in December 2018 to develop a vehicle-mounted biological-threat identifier.

Under the terms of the new contract, Kromek has been awarded up to $5.2m to further work on its mobile wide-area bio-surveillance system capable of detecting airborne pathogens. The total contract period is up to June 2021. The completed system aims to extend the existing SIGMA network for biological threats as part of DARPA’s SIGMA+ initiative.

The miniaturised system will be capable of detecting viruses and bacteria and is intended to be located on vehicles to detect the presence of a pathogenic threat. The small, unmanned system that will run all day will also be capable of being used in high footfall areas, such as hospitals and airports.

Dr Arnab Basu, CEO of Kromek, said: “We are delighted to be awarded this extension by DARPA. The technology developed under this program is capable of sample collection to comprehensive analysis of threats present in air in an autonomous manner. By sequencing the genetic code, the device can not only identify threat pathogens, but also be used to identify the particular strain to aid triage and treatment selection, in addition to being able to track mutations of the pathogen.

“As the system can be vehicle mounted or placed in high footfall areas such as hospitals and airports, the location where the sample is collected can be mapped to a GPS position. The transfer of data to a central server allows a picture of pathogen levels across a city to be built up enabling decision makers to react rapidly to any evolving pathogenic threat.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Kromek

More articles like this

Kromek

Kromek secures repeat order worth $0.8m

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a repeat order, worth $0.8m, from a US government customer for

Kromek

Kromek to enter new markets with expanded agreement

Sedgefield-based Kromek has expanded its distribution agreement with a global threat detection and security research company, which will allow it to enter new markets. Under the terms of the new agreement, Smiths Detection will market and

Kromek

Kromek wins two contracts for its nuclear security products

Developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, Kromek Group plc, has today announced that it has secured two contracts, totalling £1.5 million, for the supply of its D3M

Kromek

Kromek expands agreement with Smiths Detection

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that it has entered into a distribution agreement with Smiths Detection, a

Kromek

Kromek announces £1.5m contracts with European government bodies

North East technology firm Kromek has announced contracts totalling £1.5m for the supply of radiation detectors to two European governmental bodies. The County Durham firm, which develops and manufactures radiation and bio-detection technology solutions, is supplying

Kromek

Kromek secures two new contracts totalling £1.5m

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured two contracts, totalling £1.5m, for the supply of its D3M and D3S-based

Kromek

Contract win as market for radiation detection technology grows

Radiation and bio-detection technology firm, Kromek, has delivered a contract worth $1.3m/£1.1m for a US customer. Huddersfield-based Kromek is supplying the client with its D3M wearable radiation detector. This contract is a repeat order, with Kromek

Kromek

Kromek secures £5m contract with a UK Government department

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a contract with a UK Government department to develop and supply biological

Kromek

Kromek presents at the NATO TIDE Sprint #40 event

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, presented a paper at the Fall 2022 NATO TIDE Sprint #40 symposium being held from 24-28 October 2022 in Virginia Beach, USA. TIDE is the NATO

Kromek

The AARM – Survey large areas safely

Got a project in mind? So you need to complete a widespread environmental survey, get the go ahead for a mining or infrastructure development project. Maybe you need to plan your next steps in decommissioning a

Kromek

Kromek returns to the Counter Threat Symposium 2022

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, will be exhibiting at the Counter Threat Symposium 2022 at the Farnborough International Exhibition and Conference Centre, stand 5, from 8-10 November 2022.

Kromek

Spectrum Dynamics integrates CZT detectors in VERITON-CT 400 series

Spectrum Dynamics Medical has integrated cadmium zinc telluride (CZT) detectors from Kromek Group in its digital SPECT/CT products called the VERITON-CT 400 series. CZT is a room-temperature semiconductor, which directly transforms x-ray or gamma photons into electrons and holes. It is